Pathophysiology and Treatment of Hyperhidrosis
- PMID: 27584967
- DOI: 10.1159/000446786
Pathophysiology and Treatment of Hyperhidrosis
Abstract
Primary focal hyperhidrosis is a disease of unknown cause with profuse perspiration of local sites (head, face, palms, soles of feet, and axillae) that adversely affects daily life. Guidelines have been proposed in the USA [<citeref rid="ref1">1</citeref>], Canada [<citeref rid="ref2">2</citeref>], and Japan [<citeref rid="ref3">3</citeref>]. The symptoms impair quality of life, with significant negative effects on daily existence and personal relationships. The current goal in medical practice for patients with hyperhidrosis is to provide guidance and encourage coping skills for a normal daily life, as well as give appropriate advice regarding treatment options. On occasion, in order to improve quality of life, it is necessary to recommend surgical therapy when conservative treatment fails; this requires an understanding of the mechanisms of available treatments and their effects. This paper reviews theories of primary focal hyperhidrosis with regard to pathology, epidemiology, and treatment.
© 2016 S. Karger AG, Basel.
Similar articles
-
Focal hyperhidrosis: diagnosis and management.CMAJ. 2005 Jan 4;172(1):69-75. doi: 10.1503/cmaj.1040708. CMAJ. 2005. PMID: 15632408 Free PMC article. Review.
-
Diagnosis and management of hyperhidrosis.BMJ. 2013 Nov 25;347:f6800. doi: 10.1136/bmj.f6800. BMJ. 2013. PMID: 24277380 Review. No abstract available.
-
Treatment of focal hyperhidrosis.J Cutan Med Surg. 2007 Mar-Apr;11(2):67-77. doi: 10.2310/7750.2007.00012. J Cutan Med Surg. 2007. PMID: 17374317
-
Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy.Facial Plast Surg Clin North Am. 2007 Feb;15(1):17-30, v-vi. doi: 10.1016/j.fsc.2006.10.002. Facial Plast Surg Clin North Am. 2007. PMID: 17317552 Review.
-
Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.Arch Dermatol. 2011 Jun;147(6):752. doi: 10.1001/archdermatol.2011.143. Arch Dermatol. 2011. PMID: 21690551 No abstract available.
Cited by
-
Endoscopic thoracic sympathectomy for primary hyperhidrosis: an over a decade-long follow-up on efficacy, impact, and patient satisfaction.J Thorac Dis. 2024 Dec 31;16(12):8292-8299. doi: 10.21037/jtd-24-1407. Epub 2024 Dec 20. J Thorac Dis. 2024. PMID: 39831229 Free PMC article.
-
Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized, Sham-Controlled, Single-Blind, and Parallel-Designed Clinical Trial.Ann Dermatol. 2017 Dec;29(6):728-734. doi: 10.5021/ad.2017.29.6.728. Epub 2017 Oct 30. Ann Dermatol. 2017. PMID: 29200761 Free PMC article.
-
Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis.Aesthetic Plast Surg. 2021 Aug;45(4):1783-1791. doi: 10.1007/s00266-021-02140-7. Epub 2021 Feb 22. Aesthetic Plast Surg. 2021. PMID: 33619611 Free PMC article.
-
Primary Palmar Hyperhidrosis (PPH) Accompanied With Nevus Flammeus: A Case Report.Cureus. 2023 May 8;15(5):e38723. doi: 10.7759/cureus.38723. eCollection 2023 May. Cureus. 2023. PMID: 37292575 Free PMC article.
-
Changes in electrodermal activity following sympathicotomy in hyperhidrosis patients.Front Surg. 2024 Mar 11;11:1358357. doi: 10.3389/fsurg.2024.1358357. eCollection 2024. Front Surg. 2024. PMID: 38529470 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous